HSPA1A and type 2 diabetes mellitus: Hsp70 has also been demonstrated to suppress inflammatory cytokine production via interleukin-10-driven down-regulation of C/EBP-β and C/EBP-δ transcription factors in a fibroblast-like synoviocyte model [53]; however, currently there are no data confirming the existence of the same molecular pathway in type 2 diabetic patients.